21 CFR 862.3840 - Sirolimus test system.
(a) Identification. A sirolimus test system is a device intended to quantitatively determine sirolimus concentrations in whole blood. Measurements are used as an aid in management of transplant patients receiving therapy with sirolimus.
(b) Classification. Class II (special controls). The special control is FDA's guidance document entitled “Class II Special Controls Guidance Document: Sirolimus Test Systems.” See § 862.1(d) for the availability of this guidance document.
[69 FR 58259, Sept. 30, 2004]
Title 21 published on 2013-04-01
no entries appear in the Federal Register after this date.